Patient case activity: Mild-to-moderate migraine attacks

Shih-Pin Chen presents a patient with mild-to-moderate migraine attacks and advises on the optimum individualized therapeutic course.

In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Springer Healthcare IME. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. NACCME designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity was launched on January 28, 2021. The data were correct at time of publication and no further updates have been made to the content

Learning objectives

After taking part in this case study, you will be able to:

  • Describe how to identify and classify mild-to-moderate migraine attacks.
  • Utilize best practice recommendations to tailor treatment for patients with mild-to-moderate attacks and understand where novel therapeutics may benefit the acute treatment plan.

Shih-Pin Chen

Create a Free Account

Already Registered? Login Here

Scroll to Top

Shih-Pin Chen

Attending Neurologist and Professor, Department of Medical Research and Department of Neurology, Taipei Veterans General Hospital, Taipei, TAIWAN

Shih-Pin Chen is a physician and scientist who graduated from Faculty of Medicine and Institute of Clinical Medicine, National Yang-Ming University, Taiwan. He received his neurology resident training at Department of Neurology, Taipei Veterans General Hospital and post-doctoral fellowship training at Neurovascular Research Lab, Massachusetts General Hospital, Harvard Medical School, USA.

Dr Chen is currently an attending physician of Department of Medical Research, Taipei Veterans General Hospital and Professor of Institute of Clinical Medicine, National Yang-Ming University. He has served as the Associate Editor of Cephalalgia (the official journal of the International Headache Society) and Cephalalgia Reports since 2020. Dr Chen’s research interests focus on deciphering the pathophysiology of headache disorders, specifically, the clinical, neuroimaging, and molecular biological studies of reversible cerebral vasoconstriction syndrome (RCVS) as well as the animal models (especially cortical spreading depression) and genomics studies of migraine.


Shih-Pin Chen discloses speaker honorarium from Eli Lilly & Company.

Sign up for eAlerts or take our quiz first and sign up at the end.